Chen, J., & Cunha, R. A. (2020). The belated US FDA approval of the adenosine A(2A) receptor antagonist istradefylline for treatment of Parkinson’s disease. Purinergic Signal.
Chicago-стиль цитированияChen, Jiang-Fan, and Rodrigo A. Cunha. "The Belated US FDA Approval of the Adenosine A(2A) Receptor Antagonist Istradefylline for Treatment of Parkinson’s Disease." Purinergic Signal 2020.
MLA-цитированиеChen, Jiang-Fan, and Rodrigo A. Cunha. "The Belated US FDA Approval of the Adenosine A(2A) Receptor Antagonist Istradefylline for Treatment of Parkinson’s Disease." Purinergic Signal 2020.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.